Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
210.90
|
|
Change (%)
|
3.60 (1.74%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
208.65
-
216.00
|
|
52-Week Range (RS)
|
105.05
-
244.05
|
|
Beta (1 Year)
|
1.21
|
|
|
|
|
|
| Index Details |
| BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Board of Bliss GVS Pharma recommends interim dividend |
| Bliss GVS Pharma to conduct board meeting |
| Bliss GVS Pharma consolidated net profit rises 12.32% in the September 2025 quarter |
| Bliss GVS Pharma Ltd leads losers in 'B' group |
| Bliss GVS Pharma schedules board meeting |
| Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Comp... |
| Bliss GVS Pharma Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 |
|
|
|
| Incoporation Year : 1984 |
| Chairman : Nandkumar Kashinath Chodankar |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Formulations |
| Registered Office |
Bliss GVS Pharma Ltd
102 Hyde Park Sakivihar Road,
Andheri East,
Mumbai,
Maharashtra-400072 |
Phone:91-22-42160000
Fax:91-22-28563930 |
| E-Mail : cs@blissgvs.com; info@blissgvs.com |
| URL : http://www.blissgvs.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
13-Mar-2026 |
203.20 |
3.79 |
| 1Month |
20-Feb-2026 |
223.25 |
-5.53 |
| 3Month |
22-Dec-2025 |
175.55 |
20.14 |
| 6Month |
22-Sep-2025 |
151.40 |
39.30 |
| 1Year |
20-Mar-2025 |
120.85 |
74.51 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Motilal Oswal BSE Healthcare ETF |
0.10 |
0.04 |
| Bandhan BSE Healthcare Index Fund |
0.10 |
0.02 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Formulations |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Torrent Pharmaceuticals Ltd |
4,267.75 |
1.39 |
4,479.70 |
3,101.00 |
144,440.05 |
| Ajanta Pharma Ltd |
2,904.20 |
-1.42 |
3,158.20 |
2,022.05 |
36,283.80 |
| Gland Pharma Ltd |
1,625.20 |
1.75 |
2,130.00 |
1,200.00 |
26,776.21 |
| ERIS Lifesciences Ltd |
1,291.10 |
0.65 |
1,909.55 |
1,187.10 |
17,887.27 |
| Rubicon Research Ltd |
782.70 |
3.48 |
887.95 |
571.00 |
12,895.01 |
|
|
|
|